Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials-Reference-Cited by-同舟云学术

Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials

Published:2015-03-06 Issue:3 Volume:5 Page:253-262
ISSN:2048-8726
Container-title:European Heart Journal: Acute Cardiovascular Care
language:en
Short-container-title:European Heart Journal: Acute Cardiovascular Care

Author:

Capodanno Davide¹²,Gargiulo Giuseppe¹,Capranzano Piera¹,Mehran Roxana³,Tamburino Corrado¹²,Stone Gregg W³

Affiliation:

1. Division of Cardiology, Ferrarotto Hospital, Catania, Italy

2. Excellence Through Newest Advances (ETNA) Foundation, Catania, Italy

3. Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/2048872615572599

Reference19 articles.

1. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

2. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

3. Bivalirudin during Primary PCI in Acute Myocardial Infarction

4. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial

5. Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): An international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary intervention

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis;American Journal of Cardiovascular Drugs;2024-04-29

2. The role of intracoronary thrombolysis in thrombus-laden coronary artery: a case report;Intervenční a akutní kardiologie;2024-04-29

3. Impact of Bivalirudin on Ischemia/Reperfusion Injury in Patients with Reperfused STEMI Assessed by Cardiac Magnetic Resonance;Pharmaceuticals;2024-02-01

4. Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and management;Expert Opinion on Drug Safety;2023-12-02

5. Editorial: Bivalirudin versus unfractionated heparin in acute myocardial infarction: Why are we still debating?;Cardiovascular Revascularization Medicine;2023-11